Share-based Payment Arrangement, Expense in USD of Design Therapeutics, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Design Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2025.
  • Design Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $3.59M, a 15.1% increase year-over-year.
  • Design Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $14.6M, a 18.3% increase year-over-year.
  • Design Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13.1M, a 0.12% decline from 2023.
  • Design Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.1M, a 19.8% increase from 2022.
  • Design Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.9M, a 133% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Design Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $14.6M $3.59M +$472K +15.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $14.1M $3.99M +$686K +20.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $13.4M $3.54M +$355K +11.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $13.1M $3.47M +$747K +27.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 $12.3M $3.12M -$101K -3.14% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $12.4M $3.3M -$420K -11.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $12.8M $3.18M -$242K -7.06% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $13.1M $2.72M -$352K -11.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 $13.4M $3.22M +$347K +12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $13.1M $3.72M +$1.1M +42.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $12M $3.43M +$1.07M +45.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $10.9M $3.08M +$1.52M +97.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $9.41M $2.87M +$1.63M +131% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $7.78M $2.62M +$1.37M +111% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.4M $2.36M +$1.71M +265% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $4.69M $1.56M +$1.14M +270% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.55M $1.24M +$1.23M +8187% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.33M $1.24M +$1.23M +12330% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.09M $647K +$643K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $450K $421K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $15K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $10K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $4K* Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10

Design Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.1M -$16K -0.12% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $13.1M +$2.16M +19.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $10.9M +$6.24M +133% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $4.69M +$4.24M +942% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $450K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.